Intriguingly, these neurological symptoms persist even with complement inhibition, the most common treatment for congenital CD59 deficiency (Höchsmann and Schrezenmeier, 2015). Here, CD59 is linked to hyperinsulinemic hypoglycemia, familial, 4.